Related Experiment Video
Updated: Jun 16, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Bone marrow-derived cells contribute to fibrosis in the chronically failing heart
Po-Yin Chu1, Justin Mariani, Samara Finch
1Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Central, Melbourne, VIC 8008, Australia.
Insights
Bone marrow cells contribute to cardiac fibrosis in heart failure. Stromal-derived factor-1 (SDF-1) promotes this process, suggesting a new therapeutic target for heart disease.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Pathophysiology
Background:
- Cardiac fibrosis is a hallmark of chronic heart failure.
- The origin of fibroblasts contributing to fibrosis (native vs. bone marrow-derived) remains unclear.
Purpose of the Study:
- To determine the contribution of bone marrow-derived cells to cardiac fibrosis in heart failure.
- To investigate the role of stromal-derived factor-1 (SDF-1) in this process.
Main Methods:
- Utilized a transgenic mouse model (Mst1) of dilated cardiomyopathy.
- Assessed bone marrow-derived fibrocyte recruitment.
- Measured myocardial expression and secretion of SDF-1 by cardiomyocytes.
- Analyzed SDF-1 levels in human heart failure patients.
Main Results:
- Significantly greater bone marrow-derived cell recruitment in Mst1 mice compared to controls.
- Bone marrow cells constituted 17% of the fibroblast population in heart failure.
- Heart failure patients exhibited elevated plasma SDF-1 levels.
- Cardiomyocytes secrete SDF-1, which is upregulated by angiotensin II.
- SDF-1 increased cardiac fibroblast migration by 59%.
Conclusions:
- Bone marrow-derived cells play a significant role in cardiac fibrosis during heart failure.
- SDF-1 is implicated as a key chemoattractant in this process.
- Targeting SDF-1 may offer a therapeutic strategy for heart failure pathogenesis.
Abstract:
Cardiac fibrosis contributes significantly to the phenotype of the chronically failing heart. It is not clear whether in this setting the fibrosis is contributed by native cardiac fibroblasts or alternatively by recruitment of cells arising from the bone marrow. We aimed to determine the contribution of bone marrow-derived cells to cardiac fibrosis in the failing heart and to investigate potentially contributing cytokines. Bone marrow-derived fibrocyte recruitment to the failing heart was studied in a transgenic (Mst1 mice) model of dilated cardiomyopathy. In conjunction, we examined the role of stromal-derived factor-1 (SDF-1), a key chemoattractant, by assessing myocardial expression and secretion by cardiomyocytes and in clinical samples. Bone marrow-derived cells were recruited in significantly greater numbers in Mst1 versus control mice (P < 0.001), contributing 17 +/- 4% of the total fibroblast load in heart failure. Patients with heart failure had higher plasma levels of SDF-1 than healthy control subjects (P < 0.01). We found that cardiomyocytes constitutively secrete SDF-1, which is significantly up-regulated by angiotensin II. SDF-1 was shown to increases cardiac fibroblast migration by 59% (P < 0.05). Taken together, our data suggest that recruitment of bone marrow-derived cells under the influence of factors, including SDF-1, may play an important role in the pathogenesis of cardiac fibrosis in heart failure.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Introduction to Fibroblasts
Myocarditis I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Rheumatic Heart Disease I: Introduction

